|
Oct 2023
As of Oct 31, 2023
|
Jan 2022
As of Jan 31, 2022
|
Jul 2021
As of Jul 31, 2021
|
Oct 2020
As of Oct 31, 2020
|
Jul 2020
As of Jul 31, 2020
|
Apr 2020
As of Apr 30, 2020
|
|
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Current Assets | ||||||
| Cash | ||||||
| Total Current Assets | ||||||
| Vehicles net of depreciation (Note 3) | ||||||
| Other Assets | ||||||
| Investment in Subsidiary | ||||||
| Intangible asset, net of amortization (Note 4) | ||||||
| Other assets | ||||||
| TOTAL ASSETS | ||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | ||||||
| LIABILITIES | ||||||
| Accounts Payable | ||||||
| Other Current Liabilities (Note 11) | ||||||
| Accrued Interest Payable | ||||||
| Due to related party ( Note 7) | ||||||
| Due to related party (Note 7) | ||||||
| Notes Payable (Note 8) | ||||||
| Convertible Notes Payable (Note 9) | ||||||
| Total Current Liabilities | ||||||
| TOTAL LIABILITIES | ||||||
| Preferred stock, value | ||||||
| Series A Preferred Stock | ||||||
| Series B Preferred Stock | ||||||
| Series C Preferred Stock | ||||||
| Common Stock, $.001 par value 10,000,000,000 Authorized 6,541,760,129 Issued and Outstanding on October 31, 2023, and 5,490,239,323 on April 30, 2023 | ||||||
| Additional paid-in-capital | ||||||
| Accumulated deficit | ||||||
| Total Stockholders’ Equity (Deficit) | ||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | ||||||
Loading...
